C4 THERAPEUTICS INC (CCCC) Stock Cash Flow
NASDAQ:CCCC - Nasdaq - US12529R1077 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -105.50M | -132.49M | -128.18M | -83.89M | -66.34M | |||
| Depreciation Amortization | 1.77M | 1.88M | 1.68M | 1.49M | 1.62M | |||
| Change In Working Capital | 3.63M | -6.94M | -16.78M | -30.09M | -13.18M | |||
| Interest Paid | 0.00 | 990.00K | 1.62M | 1.31M | 820.00K | |||
| Taxes Paid | N/A | 1.00M | N/A | 0.00 | 140.00K | |||
| Other non cash items | 28.87M | 30.71M | 37.34M | 25.53M | 10.65M | |||
| OPERATING CASH FLOW | -71.23M | -106.84M | -105.94M | -86.97M | -67.25M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -341.00K | -1.71M | -5.50M | -1.28M | -650.00K | |||
| Other Investing Activity | -32.65M | 160.06M | 63.92M | -188.06M | -189.86M | |||
| INVESTING CASH FLOW | -32.99M | 158.35M | 58.42M | -189.34M | -190.51M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -12.50M | N/A | 0.00 | 11.97M | |||
| Stock Issued/Repurchased | 102.52M | 57.62M | 780.00K | 2.04M | 336.96M | |||
| Other Financing Activity | 380.00K | 368.00K | 370.00K | 169.36M | N/A | |||
| FINANCING CASH FLOW | 102.90M | 45.49M | 1.15M | 171.40M | 348.93M | |||
| CHANGE IN CASH | -1.33M | 97.00M | -46.37M | -104.91M | 91.17M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -71.23M | -106.84M | -105.94M | -86.97M | -67.25M | |||
| Capital Expenditure | -341.00K | -1.71M | -5.50M | -1.28M | -650.00K | |||
| FREE CASH FLOW | -71.57M | -108.55M | -111.44M | -88.25M | -67.90M | |||
All data in USD